Navigation Links
ViroPharma Enhances Leadership to Support Global Growth and Expanding Business
Date:10/20/2008

- Company Appoints Charles Rowland to Chief Financial Officer -

EXTON, Pa., Oct. 20 /PRNewswire-FirstCall/ -- ViroPharma Incorporated (Nasdaq: VPHM) today announced that it has appointed its new chief financial officer, and strengthened its leadership in human resources, clinical development and medical affairs. Charles Rowland has joined the company as vice president and chief financial officer; Thomas Macnamara has been promoted to the position of vice president, human resources; Steven Gelone, Pharm. D. has transitioned to the role of vice president, clinical development programs; and Glenn Tillotson, Ph. D. has joined the company as head of medical affairs.

"It is essential that we have strong leaders throughout our organization that can optimize the development of ViroPharma, particularly as our business expands and we grow the organization globally," commented Vincent Milano, ViroPharma's president and chief executive officer. "These enhancements augment our already strong team. Charlie, Steve, Tom and Glenn have the right experience, integrity and drive to help direct ViroPharma into its next phase of growth and success."

Charles A. Rowland Jr., CPA, MBA, has 28 years of diversified experience across a broad field of financial areas. As vice president and chief financial officer, Mr. Rowland will be responsible for all areas of finance and accounting, including financial reporting, tax, treasury, and strategic financial planning. Most recently, he was the executive vice president and chief financial officer for Endo Pharmaceuticals, as well serving for a period as co-interim chief executive officer. At Endo, Mr. Rowland drove the strategic planning process through two successive chief executive officers. He a
'/>"/>

SOURCE ViroPharma Incorporated
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. ViroPharma to Present at Two Upcoming Healthcare Conferences
2. ViroPharma Provides 2008 Outlook
3. ViroPharma to Present at the BIO CEO & Investor Conference
4. ViroPharma to Release 2007 Fourth Quarter and Full Year Financial Results on February 27, 2008
5. ViroPharma to Present at the Susquehanna Financial Group Second Annual Significant Options in Healthcare Conference
6. ViroPharma to Present at the Cowen & Company 28th Annual Healthcare Conference
7. ViroPharma to Present at the Seventh Annual JMP Securities Research Conference
8. ViroPharma to Present at Two Upcoming Healthcare Conferences
9. Viropharma Comments On Upcoming FDA Advisory Committee Meeting
10. ViroPharma Provides Update on Upcoming FDA Advisory Committee Meeting to Discuss Bioequivalence of Locally Acting Gastrointestinal Drugs
11. ViroPharma To Acquire Lev Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)... 2 Martek Biosciences Co... intends to release the results of its fourth quar...approximately 4:00 p.m. Eastern Time (ET). Follow...ct a conference call to discuss these results with...the call live via webcast by visiting Martek,s web...
(Date:12/2/2009)...Newswire-USNewswire/ -- Nearly 600 medical researc...rs today convened to explore novel development app...naugural Partnering for Cures meeting. ,, F...lken Institute, convened Partnering for Cures to...turn a scientific discovery into an accessible the...
(Date:12/2/2009)...therlands, December 2 Pepscan Hold...y focusing on protein mimicking,technology for the... that it,has appointed Wim E.M. Mol, Ph.D. as new ...e responsible for all of Pepscans corporate functi...tion of the company. He brings to,Pepscan more tha...
(Date:12/2/2009)..., Dec. 2 /PRNewswire-Asia/ -- Simcere Pharmaceutic... ), a leading pharmaceutical company,specializing ...f branded,generic and proprietary pharmaceuticals ...ve been included in China,s National Drug Reimburs...inistry of Human Resources and Social,Security on ...
Breaking Biology Technology:Martek to Announce Fourth Quarter and Fiscal Year 2009 Results 2Medical Research Leaders Explore Novel Strategies to Expedite the Search for Cures 2Dutch Biotech Company Pepscan Appoints New CEO 2Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 2Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 3
...d for Targeting Tumors and Other, Abnormalities w...urgery, PALO ALTO, Calif., Sept. 18 Varian Medic...0(k) clearance for a new,high-definition multileaf...ce for radiosurgery. The new HD120 MLC multileaf ... precise radiosurgical treatments, including inten...
...cals Plc, a,private biopharmaceutical company focu...flammatory drugs, announced today that it has,appo...Chief Executive,Officer. Dr. Mazanet has significa...nagement in the biopharmaceutical industry. Dr. M... public,pharmaceutical companies. From June 1998 t...
...apies today,announced it has developed a novel ser... the treatment of female sexual dysfunction (FSD)....nt inhibitors designed to,regulate neuronal activi...elieves these compounds may have utility in the tr...), a condition that affects a significant,percenta...
Other Biology Technology:Varian Medical Systems Receives FDA 510(k) Clearance for High-Definition Collimator That Enables Ultra-Fine Intensity-Modulated Radiosurgery 2Varian Medical Systems Receives FDA 510(k) Clearance for High-Definition Collimator That Enables Ultra-Fine Intensity-Modulated Radiosurgery 3Morria Biopharmaceuticals Plc Announces Appointment of Dr. Rosemary Mazanet as Interim Chief Executive Officer 2Intra-Cellular Therapies Provides Overview of its Proprietary Portfolio of Compounds for the Treatment of Female Sexual Dysfunction (FSD) 2Intra-Cellular Therapies Provides Overview of its Proprietary Portfolio of Compounds for the Treatment of Female Sexual Dysfunction (FSD) 3
(Date:12/4/2009)... Leskovar, a Texas AgriLife Research plant physiol... Center in Uvalde, has been investigating ways to ...tion from the greenhouse to the field. , "This r...ossibly even the further profitability of some veg...ive plants that will establish well," Leskovar sai...
(Date:12/4/2009)...vailable in German . , A new study of the Max... to understand the positive effect of dietary rest...different organisms (fruit flies and mice) have sh...but with a potential negative side effect of dimin...s less frequently with a reduced litter size on a ...
(Date:12/3/2009)...earn new information and adapt to changes in our d...mories, appears to lie in the minute junctions whe...dy by NYU Langone Medicine Center researchers. The...l Nature . , The scientists, led by Wen-Biao G...roscience at NYU School of Medicine, discovered th...
Breaking Biology News(10 mins):Texas AgriLife researchers helping 2Texas AgriLife researchers helping 3Texas AgriLife researchers helping 4How nutrition affects healthy aging 2Lifelong memories linked to stable nerve connections 2Dr James OConnell Named J H Kanter Prize Laureate 54148 1Dr James OConnell Named J H Kanter Prize Laureate 54148 2Dr James OConnell Named J H Kanter Prize Laureate 54148 3Kevin Nealon Jordan Farmar Walter Perez Cristian de la Fuente and Other Celebrities Participated in Beach Volleyball Match for Children With Cancer 54145 1Kevin Nealon Jordan Farmar Walter Perez Cristian de la Fuente and Other Celebrities Participated in Beach Volleyball Match for Children With Cancer 54145 2Kevin Nealon Jordan Farmar Walter Perez Cristian de la Fuente and Other Celebrities Participated in Beach Volleyball Match for Children With Cancer 54145 3William Stanfield MD Is First Cleveland area Orthopedic Surgeon to Perform OtisKnee Custom Fit Knee Replacement 13481 1William Stanfield MD Is First Cleveland area Orthopedic Surgeon to Perform OtisKnee Custom Fit Knee Replacement 13481 2William Stanfield MD Is First Cleveland area Orthopedic Surgeon to Perform OtisKnee Custom Fit Knee Replacement 13481 3William Stanfield MD Is First Cleveland area Orthopedic Surgeon to Perform OtisKnee Custom Fit Knee Replacement 13481 4
...ne of the central challenges of our time is the su...ce-efficient energy to our society. In this contex...rtance. Bjrn Loges, Albert Boddien, Henrik Junge, ...talysis in Rostock have now succeeded in the contr...ut the need for the high-temperature reforming pro...
...ware, WALL, N.J., May 6 BIO-key International, I...-based biometric,identification and wireless publi...e showcasing its latest mobile data solution for B...forcement Information Management,(LEIM) Conference...t and,Convention Center in Nashville, TN., The LE...
...e exploited to make them more sensitive to heat an...School of Medicine in St. Louis report. , The Was...found that tumors have a built-in mechanism that p...ost likely decreases the benefit of hyperthermia a...ing with that protection, the researchers have sho...
Other Biology News:Power from formic acid 2BIO-key(R) Showcasing Public Safety Solutions for BlackBerry Smartphones at 2008 LEIM Conference 2BIO-key(R) Showcasing Public Safety Solutions for BlackBerry Smartphones at 2008 LEIM Conference 3Researchers find way to make tumor cells easier to destroy 2
... Clean-up Micro Kit provides a fast and simple pro...100 and other detergents from small samples of pro...sing Norgens patented protein resin as an ion exch... of either acidic or basic protein.A complete kit ...
...is critical to the maintenance of appropriate leve...tant and diverse as those involved in cellular met...resentation, modulation of cell surface receptors ...tion, and signalling factors. The ubiquitin-protea...
...ion Service includes 1. Scanning of gel(s) 2. Exci...yptic in-gel digestion and peptide extraction 4. P...of PMF (Peptide Mass Fingerprint) spectra via MALD...PFF (Peptide Fragmentation Fingerprint) spectra vi...
Yeast-GFP 96-well Plates from Invitrogen
Biology Products: